Canada has lost its measles elimination status after nearly three decades, following a year-long outbreak that the Pan American Health Organization (PAHO) confirmed on Monday. The setback also affects the Americas region, which now loses its measles-free designation.
According to PAHO Director Dr. Jarbas Barbosa, the loss is “reversible” but serves as a warning to strengthen public health efforts. Canada has reported over 5,000 measles cases across nine provinces and one northern territory, with under-vaccinated communities driving the prolonged transmission.
Health experts say the resurgence of measles highlights serious lapses in vaccination outreach and growing vaccine hesitancy since the COVID-19 pandemic. Dr. Isaac Bogoch, an infectious disease specialist at Toronto General Hospital, described the situation as “a wake-up call” for Canada to improve accessibility and trust in immunization programs.
To maintain herd immunity, a 95% vaccination rate is required, as the measles vaccine is 97% effective after two doses. However, declining vaccination rates have allowed the virus to spread more easily, posing severe risks to children and vulnerable populations.
The Public Health Agency of Canada stated that while the spread has slowed, the outbreak persisted for over 12 months. The agency pledged to boost vaccination coverage, strengthen surveillance systems, and improve data sharing nationwide.
In Alberta, one of the hardest-hit provinces, cases have dropped by over 90% from their peak, with vaccination rates up 50% since March. Despite these gains, experts warn that losing measles elimination status is “a step backward,” symbolizing a return to preventable disease risks.
Other countries in the Americas, including the United States, Mexico, and Brazil, are also facing outbreaks as global vaccination rates decline—a concerning trend that could reverse decades of public health progress.


Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
DOJ Sues Loudoun County School Board Over Transgender Locker Room Policy
Major Drugmakers Slash U.S. Prices and Sell Directly to Patients Amid Trump’s Push for Affordable Medicines
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market
Southwest Airlines Has $11 Million Fine Waived as USDOT Cites Operational Improvements
Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence
Trump Set to Begin Final Interviews for Next Federal Reserve Chair
Novo Nordisk Appoints Greg Miley to Lead Corporate Affairs Amid U.S. Drug Pricing Pressure
U.S. State Department Reverts to Times New Roman in Push for “Professionalism”
U.S. Homeland Security Ends TSA Union Contract, Prompting Legal Challenge
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths
Senate Set for Vote on GOP Healthcare Plan as Debate Over ACA Subsidies Intensifies
Taiwan Opposition Criticizes Plan to Block Chinese App Rednote Over Security Concerns
U.S. Reveals 2026 Medicare Star Ratings: Aetna, UnitedHealth Lead in Quality Scores
US Charges Two Men in Alleged Nvidia Chip Smuggling Scheme to China
China Adds Domestic AI Chips to Government Procurement List as U.S. Considers Easing Nvidia Export Curbs
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment 



